Skip to main content
Clinical Trials/NCT02621437
NCT02621437CompletedNot Applicable

Study of the Impact of Osteopathic Care, Complementary Therapy to Standard Care, on Pain in Patients With Breast Cancer Surgery

Hospices Civils de Lyon1 site in 1 country161 target enrollmentStarted: February 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
161
Locations
1
Primary Endpoint
Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Study Overview

Brief Summary

Breast cancer can be painful following surgery or can develop later and remain persistent. Pain occurrence is frequent with 50% of women developing sequelae pain of varying intensity with an impact on the quality of life. One of the priorities of the 3rd French Cancer Plan is to preserve quality of life.

Osteopathy, complementary therapy, may help to reduce inconvenience caused by the disease, treatments and their side effects (asthenia, anxiety and pain).

The main objective is to assess the impact of osteopathic treatment on pain in patients following breast cancer surgery. The impact will be considered beneficial if the pain score (digital scale) in the intervention group is lower, by at least two points, than the pain score in the control group at the end of the study.

This is a monocentric, randomized, parallel group, single-blind and prospective clinical trial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult woman
  • •Surgery for a malignant breast tumor with sentinel lymph node technique
  • •Patient affiliated to a social security system
  • •Willing and able to provide written informed consent

Exclusion Criteria

  • •Under-age women
  • •Pregnant woman
  • •Surgery for a malignant breast tumor with lymph node dissection
  • •Receiving adjuvant therapy during the study
  • •Receiving physiotherapy sessions (other than those made in immediate post-operative)
  • •Participating in the space "Au Fil de Soi": relaxing body massage and Energy Resonance by Cutaneous Stimulation (RESC)
  • •Person under guardianship or supervision
  • •Patient with impaired cognitive functions or lack of understanding of the French language
  • •Presenting a contraindication for osteopathy (major infectious and inflammatory conditions, trauma and other severe diseases)

Arms & Interventions

Intervention group (osteopathy)

Experimental

Patients will have three sessions of osteopathy and 6 phone questionnaires.

Intervention: Osteopathy sessions (Other)

Intervention group (osteopathy)

Experimental

Patients will have three sessions of osteopathy and 6 phone questionnaires.

Intervention: phone questionnaires (Other)

control group

Other

Patients will have 6 phone questionnaires.

Intervention: phone questionnaires (Other)

Outcomes

Primary Outcomes

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at Day 48

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at Day 9

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at day 20

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at day 26

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at Day 34

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Assess the impact of osteopathic treatment on pain in patients following breast cancer surgery

Time Frame: at Day 40

The primary outcome measure will be the evaluation of the "usual pain in the last eight days" measured from the pain score (digital scale). The pain score consists of asking the patient to quantify her pain on a virtual scale from 0 (absent pain) to 10 (worst pain imaginable).

Secondary Outcomes

  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 48)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 48)
  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 9)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 9)
  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 20)
  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 26)
  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 34)
  • Assess the impact of osteopathic treatment on the quality of life in patients who have been operated on breast cancer.(at day 40)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 20)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 26)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 34)
  • Assess the impact of osteopathic treatment on the reduction of anxiety of patients operated for breast cancer.(at Day 40)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials